Physician profile
Kartik Ananth
NPI 1821279423
$4,947.44
in general payments reported to CMS, 2019-2025
49 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $827 · 2021: $629 · 2022: $625 · 2023: $564 · 2024: $846 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,486.23 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $500.56 | 2019-2025 | Eterna, Proclaim, Ionicrf |
| Abbvie INC. | $245.96 | 2021-2023 | Botox |
| Nevro Corp. | $235.60 | 2019-2020 | |
| Spr Therapeutics, INC | $225.80 | 2023-2025 | Sprint Pns System |
| Lundbeck LLC | $188.76 | 2020-2022 | |
| Biodelivery Sciences International, INC. | $164.06 | 2019-2021 | |
| Eisai INC. | $152.31 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $150.28 | 2019-2020 | |
| Medtronic, INC. | $110.28 | 2021-2022 | |
| Allergan, INC. | $105.47 | 2019-2020 | |
| Novo Nordisk INC | $89.59 | 2025 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $89.51 | 2020-2021 | |
| Horizon Therapeutics Plc | $87.82 | 2019-2020 | |
| Medtronic USA, INC. | $82.82 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kartik Ananth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.